Norepinephrine

Lore & Background

Norepinephrine is synthesized from the amino acid tyrosine through a series of enzymatic steps, with dopamine as its direct precursor. The conversion of dopamine to norepinephrine occurs predominantly inside neurotransmitter vesicles, catalyzed by dopamine β-monooxygenase. In the brain, norepinephrine is produced in the locus coeruleus, a small nucleus in the pons that exerts powerful effects on other brain areas. Outside the brain, it is released by sympathetic ganglia and Merkel cells in the skin, as well as directly into the bloodstream by the adrenal glands. Norepinephrine acts by binding to adrenergic receptors on cell surfaces, which are divided into alpha and beta families. Its release is lowest during sleep, rises during wakefulness, and reaches high levels during stress or danger. In the brain, it increases arousal, alertness, vigilance, memory formation and retrieval, and attention, but also restlessness and anxiety. In the body, it increases heart rate and blood pressure, triggers glucose release, increases blood flow to skeletal muscle, and reduces blood flow to the gastrointestinal system. Many medically important drugs work by altering norepinephrine systems. Norepinephrine itself is used as an injectable drug for critically low blood pressure. Stimulants like amphetamine act as reuptake inhibitors and increase catecholamine signaling. Beta blockers counter some effects by blocking beta-adrenergic receptors, while alpha blockers and alpha-2 agonists have various therapeutic uses, including treating hypertension, anxiety, and ADHD.

Reader's Guide

Norepinephrine is significant as a central mediator of the body's stress response and a key regulator of arousal, attention, and cardiovascular function. Its dual role as a neurotransmitter and hormone allows it to coordinate rapid physiological and behavioral changes during fight-or-flight situations. The discovery and characterization of its synthesis, storage, release, and receptor interactions have enabled the development of numerous therapeutic drugs. Beta blockers, which block beta-adrenergic receptors, are used to treat glaucoma, migraines, and cardiovascular diseases by reducing myocardial oxygen demand. Alpha-2 agonists, such as guanfacine, have shown effectiveness in treating anxiety disorders and ADHD, though the reasons remain unclear. Stimulants and antidepressants that affect norepinephrine reuptake are widely prescribed for conditions like ADHD and depression. The legacy of norepinephrine research lies in its profound impact on pharmacology and medicine, providing targets for drugs that manage blood pressure, heart conditions, psychiatric disorders, and more. Its study continues to inform understanding of stress, cognition, and autonomic nervous system function.

Did You Know?

• Norepinephrine is also called noradrenaline; the name 'norepinephrine' is preferred in the United States, while 'noradrenaline' is more common in the United Kingdom and the rest of the world.
• Norepinephrine release is lowest during sleep, rises during wakefulness, and reaches much higher levels during stress or danger in the fight-or-flight response.
• The direct precursor of norepinephrine is dopamine, which is synthesized from the amino acid tyrosine.
• Beta blockers, which counter some effects of noradrenaline by blocking beta-adrenergic receptors, are used to treat glaucoma, migraines, and cardiovascular diseases.